Stock Events

Stock Events

10x Genomics 

€59.06
189
+€2.02+3.54% Friday 19:46

Statistics

Day High
59.69
Day Low
56.6
52W High
59.06
52W Low
9.47
Volume
-
Avg. Volume
-
Mkt Cap
7.69B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4NovExpected
Q4 2025
Q1 2026
Q2 2026
Next
-0.23
-0.18
-0.14
-0.09
Expected EPS
-0.2244758217
Actual EPS
N/A

Financials

-7.11%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
558.3MRevenue
-39.71MNet Income

Analyst Ratings

$36.56Average Price Target
The highest estimate is 53.12.
From 12 ratings within the last 6 months. This is not an investment recommendation.
Buy
33%
Hold
67%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1KJ.STU. It's not an investment recommendation.
Apple
47
AAPL
NVIDIA
47
NVDA
Microsoft
44
MSFT
Tesla
42
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap32.95B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with technologies that overlap with 10x Genomics' offerings.
Pacific Biosciences of California
PACB
Mkt Cap419.62M
Pacific Biosciences offers long-read sequencing technologies that compete with 10x Genomics' products for genomic and transcriptomic analysis.
Bionano Genomics
BNGO
Mkt Cap14.13M
Bionano Genomics provides optical genome mapping solutions, which compete with 10x Genomics' chromosomal conformation capture technologies.
Intellia Therapeutics
NTLA
Mkt Cap1.79B
Intellia Therapeutics is involved in CRISPR gene editing, a field that requires detailed genomic analysis, where 10x Genomics' products are used.
CRISPR Therapeutics
CRSP
Mkt Cap5.39B
CRISPR Therapeutics is another key player in the gene editing space, relying on genomic insights where 10x Genomics' technologies can be applied.
Editas Medicine
EDIT
Mkt Cap496.06M
Editas Medicine operates in the genome editing sector, competing for the same genomic analysis market as 10x Genomics.
Teladoc Health
TDOC
Mkt Cap1.14B
Teladoc Health, while primarily a telehealth company, is expanding into primary care and chronic condition monitoring, indirectly competing with 10x Genomics in the data analysis and personalized medicine space.
Guardant Health
GH
Mkt Cap21.66B
Guardant Health specializes in liquid biopsies and cancer diagnostics, competing with 10x Genomics in the genomic analysis market for oncology.
Twist Bioscience
TWST
Mkt Cap8.21B
Twist Bioscience operates in the synthetic biology space, producing synthetic DNA that is used in many of the same applications as 10x Genomics' products.

About

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
Show more...
CEO
Serge Saxonov
Employees
1178
Country
United States
ISIN
US88025U1097
WKN
000A2PPQJ

Listings

LSE
GB
0A88.LSE
STU
DE
1KJ.STU
XNAS
US
TXG
MU
DE
1KJ.MU

0 Comments

Share your thoughts

FAQ

What is 10x Genomics stock price today?▼
The current price of 1KJ.STU is €59.06 EUR — it has increased by +3.54% in the past 24 hours. Watch 10x Genomics stock price performance more closely on the chart.
What is 10x Genomics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange 10x Genomics stocks are traded under the ticker 1KJ.STU.
Is 10x Genomics stock price growing?▼
1KJ.STU stock has risen by +9.65% compared to the previous week, the month change is a +19.33% rise, over the last year 10x Genomics has showed a +442.83% increase.
What is 10x Genomics market cap?▼
Today 10x Genomics has the market capitalization of 7.69B
When is the next 10x Genomics earnings date?▼
10x Genomics is going to release the next earnings report on November 04, 2026.
What were 10x Genomics earnings last quarter?▼
1KJ.STU earnings for the last quarter are -0.12 EUR per share, whereas the estimation was -0.21 EUR resulting in a +42.41% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is 10x Genomics revenue for the last year?▼
10x Genomics revenue for the last year amounts to 558.3M EUR.
What is 10x Genomics net income for the last year?▼
1KJ.STU net income for the last year is -39.71M EUR.
How many employees does 10x Genomics have?▼
As of September 13, 2026, the company has 1,178 employees.
In which sector is 10x Genomics located?▼
10x Genomics operates in the Health & Wellness sector.
When did 10x Genomics complete a stock split?▼
10x Genomics has not had any recent stock splits.
Where is 10x Genomics headquartered?▼
10x Genomics is headquartered in PLEASANTON, United States.